Pure Foods Tasmania strikes deal for Brilliant Food Australia, expands seafood footprint

SYDNEY – Pure Foods Tasmania Ltd (ASX: PFT) said on Thursday it has entered a binding agreement to acquire the assets of premium seafood brand Brilliant Food Australia Pty Ltd…

NNR April 2, 2026

Euronext

JCDecaux to buy Tokyo based Vista Communications Inc.

PARIS – JCDecaux SE (Euronext Paris: DEC), the number one outdoor advertising company worldwide, has signed an agreement to acquire Vista Communications Inc., a Japanese company specialising in advertising on taxi…

NNR April 1, 2026

Nasdaq Nordic

Hacksaw Ventures Invests in Jinx Gaming, Strengthening OpenRGS Partnership

STOCKHOLM: Hacksaw Ventures, a part of Hacksaw Gaming, has entered into an agreement to invest in Jinx Gaming, a current partner studio on the OpenRGS platform, and has become a…

NNR April 1, 2026

Nasdaq Nordic

Defensor Group appoints Niclas Colliander as Group Chief Executive Officer

STOCKHOLM: Defensor Group AB today announced the appointment of Niclas Colliander as Group Chief Executive Officer. The appointment marks the next phase in the company’s development and reinforces its ambition…

NNR April 1, 2026

Nasdaq Nordic

Nordic Transport Group appoints Carsten Trolle as CEO of its Air & Ocean division

COPENHAGEN: NTG Nordic Transport Group announced the appointment of Carsten Trolle as CEO of its Air & Ocean division, effective immediately. Carsten brings extensive expertise to NTG, having successfully managed…

NNR April 1, 2026

London Stock Exchange

Eli Lilly to acquire Centessa Pharmaceuticals for $6.3 billion

LONDON - Eli Lilly and Company has entered into a definitive agreement to acquire public portfolio company Centessa Pharmaceuticals plc. ("Centessa", Nasdaq: CNTA). Centessa is a clinical-stage biotech developing a…

NNR April 1, 2026

London Stock Exchange

Biogen Inc. agrees to acquire Apellis Pharmaceuticals for $5.6 billion

LONDON - Biogen Inc. ("Biogen", Nasdaq: BIIB) has entered into a definitive agreement to acquire public portfolio company Apellis Pharmaceuticals, Inc. ("Apellis", Nasdaq: APLS). Apellis is a commercial-stage biotech advancing…

NNR April 1, 2026

Australian Exchange

Count Limited to acquire Oracle Group, launch $40.9 mln equity raising

SYDNEY: Count Limited (ASX:CUP) said on Tuesday it will acquire Oracle Group in a deal valued at about A$72.2 million ($47.5 million), expanding its financial advice and accounting footprint across…

NNR March 31, 2026

London Stock Exchange

Amani closes $25 million Series A financing

LONDON: RTW Biotech Opportunities Ltd (the "Company" or "RTW Bio"), the London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector,…

NNR March 31, 2026

Metals One secures 30% stake in South African gold venture

LONDON: Metals One (AIM: MET1, OTCQB: MTOPF) has converted its $1.8 million convertible loan notes into a 30% stake in Lions Bay Resources Pty Ltd (LBR), a privately held South…

NNR March 31, 2026

London Stock Exchange

Mundys acquires up to 9.5% of Getlink share capital

LONDON: Mundys today announced that it strengthens its strategic position in Getlink with the acquisition of up to 9.5% of Getlink share capital. 3.5% of Getlink’s share capital will be acquired…

NNR March 31, 2026

Australian Exchange

Advanced Innergy offers $0.40 per share for Matrix Composites, secures call options for 19.9% stake

SYDNEY: Advanced Innergy Holdings Ltd (ASX:AIH) has submitted a non-binding indicative proposal to acquire Matrix Composites & Engineering Ltd (ASX:MCE) for A$0.40 per share in cash, the company said on…

NNR March 30, 2026